Evidence map›Paper›PMID 36273134›Full record

ArticleJournal of neuroinflammation2022

FoxP3 expression by retinal pigment epithelial cells: transcription factor with potential relevance for the pathology of age-related macular degeneration.

Ahmad Samir Alfaar, Lucas Stürzbecher, Maria Diedrichs-Möhring, Marion Lam, Christophe Roubeix, Julia Ritter, Kathrin Schumann, Balasubramaniam Annamalai, Inga-Marie Pompös, Bärbel Rohrer and 4 more

Open access · goldAbstract read
In one paragraph

Article in Journal of neuroinflammation, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Rac1 overexpression promotes Treg-derived cytokines to mediate choroidal neovascularization in wet age-related macular degeneration.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 8 institutions in 3 countries.

Ahmad Samir AlfaarExperimental Ophthalmology, Department of Ophthalmology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität, Berlin Institute of Health, Humboldt-University, 10117, Berlin, Germany.
Lucas StürzbecherExperimental Ophthalmology, Department of Ophthalmology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität, Berlin Institute of Health, Humboldt-University, 10117, Berlin, Germany.
Maria Diedrichs-MöhringSection of Immunobiology, Department of Ophthalmology, University Hospital, LMU Munich, 80336, Munich, Germany.
Marion LamInstitut de La Vision, Sorbonne Université, INSERM, CNRS, 75012, Paris, France.
Christophe RoubeixInstitut de La Vision, Sorbonne Université, INSERM, CNRS, 75012, Paris, France.
Julia RitterInstitut Für Med. Mikrobiologie, Immunologie Und Hygiene, TU München, 81675, Munich, Germany.
Kathrin SchumannInstitut Für Med. Mikrobiologie, Immunologie Und Hygiene, TU München, 81675, Munich, Germany.
Balasubramaniam AnnamalaiDepartment of Ophthalmology, College of Medicine, Medical University South Carolina, Charleston, SC, 29425, USA.
Inga-Marie PompösExperimental Ophthalmology, Department of Ophthalmology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität, Berlin Institute of Health, Humboldt-University, 10117, Berlin, Germany.
Bärbel RohrerDepartment of Ophthalmology, College of Medicine, Medical University South Carolina, Charleston, SC, 29425, USA.
Florian SennlaubInstitut de La Vision, Sorbonne Université, INSERM, CNRS, 75012, Paris, France.
Nadine Reichhart *Experimental Ophthalmology, Department of Ophthalmology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität, Berlin Institute of Health, Humboldt-University, 10117, Berlin, Germany.
Gerhild Wildner *Section of Immunobiology, Department of Ophthalmology, University Hospital, LMU Munich, 80336, Munich, Germany. Gerhild.Wildner@med.uni-muenchen.de.
Olaf Strauß *Experimental Ophthalmology, Department of Ophthalmology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität, Berlin Institute of Health, Humboldt-University, 10117, Berlin, Germany. Olaf.strauss@charite.de.
Charité - Universitätsmedizin Berlin · DEHumboldt-Universität zu Berlin · DEMedical University of South Carolina · USSorbonne Université · FRInserm · FRLMU Klinikum · DELudwig-Maximilians-Universität München · DEUniversity Hospital Ulm · DE

Funding

Sex and Gender Supplement to Elastase and Elastin Peptide Activity in Age-Related Macular DegenerationR01EY030072 · NEI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI ROHRER, BAERBEL · 2020 to 2024
$1.9M
Dr. Werner Jackstaedt-Stiftung Stiftung not given; ID by dateNEI NIH HHS R01 EY030072the Einstein Foundation/BIH Visiting Fellow Program ID by Visiting Fellow Sennlaub
6 · The paper itself

Abstract

backgroundForkhead-Box-Protein P3 (FoxP3) is a transcription factor and marker of regulatory T cells, converting naive T cells into Tregs that can downregulate the effector function of other T cells. We previously detected the expression of FoxP3 in retinal pigment epithelial (RPE) cells, forming the outer blood-retina barrier of the immune privileged eye.

methodsWe investigated the expression, subcellular localization, and phosphorylation of FoxP3 in RPE cells in vivo and in vitro after treatment with various stressors including age, retinal laser burn, autoimmune inflammation, exposure to cigarette smoke, in addition of IL-1β and mechanical cell monolayer destruction. Eye tissue from humans, mouse models of retinal degeneration and rats, and ARPE-19, a human RPE cell line for in vitro experiments, underwent immunohistochemical, immunofluorescence staining, and PCR or immunoblot analysis to determine the intracellular localization and phosphorylation of FoxP3. Cytokine expression of stressed cultured RPE cells was investigated by multiplex bead analysis. Depletion of the FoxP3 gene was performed with CRISPR/Cas9 editing.

resultsRPE in vivo displayed increased nuclear FoxP3-expression with increases in age and inflammation, long-term exposure of mice to cigarette smoke, or after laser burn injury. The human RPE cell line ARPE-19 constitutively expressed nuclear FoxP3 under non-confluent culture conditions, representing a regulatory phenotype under chronic stress. Confluently grown cells expressed cytosolic FoxP3 that was translocated to the nucleus after treatment with IL-1β to imitate activated macrophages or after mechanical destruction of the monolayer. Moreover, with depletion of FoxP3, but not of a control gene, by CRISPR/Cas9 gene editing decreased stress resistance of RPE cells.

conclusionOur data suggest that FoxP3 is upregulated by age and under cellular stress and might be important for RPE function.

Indexed as

Macular DegenerationRetinal Pigment EpitheliumAnimalsCells, CulturedEpithelial CellsForkhead Transcription FactorsHumansInflammationMiceRatsRetinal PigmentsTranscription FactorsForkhead Transcription FactorsFOXP3 protein, humanFoxp3 protein, mouseFoxp3 protein, ratRetinal PigmentsTranscription FactorsAge-related macular degenerationCa-channelsCRISPR/Cas9FoxP3IL-1βImmune barrierImmune privilege of the retinaPhosphorylationRPE

Identifiers

PMID36273134
PMCPMC9588251
OpenAlexW4307135255

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.